After landing a $354M payout, Medivation CEO David Hung doesn’t overlook his 2016 bonus
It’s been a very good year at Medivation, numbers wise. So now that CEO David Hung has completed his $14 billion deal to sell the company to Pfizer, securing a $354 million exit package on the way, what’s left to do?
Why, arrange 2016 bonuses for himself and the executive crew, of course.
Medivation won’t see the end of the year as an independent company, but that’s not a deal breaker. The accountants calculated how the company was doing so far and then extrapolated the data to cover the rest of the year. And by that measure, the team qualified for a 128% payout rate.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.